Talaia Carlos, Queiroz Glória, Pinheiro Helder, Moura Daniel, Gonçalves Jorge
Laboratory of Pharmacology, CEQOFFUP, Faculty of Pharmacy, University of Porto, Rua Aníbal Cunha, 164, 4050-047 Porto, Portugal.
Neurochem Int. 2006 Dec;49(7):698-707. doi: 10.1016/j.neuint.2006.07.002. Epub 2006 Sep 7.
The influence of alpha2-autoreceptors on the facilitation of [3H]-noradrenaline release mediated by angiotensin II was studied in prostatic portions of rat vas deferens preincubated with [3H]-noradrenaline. Angiotensin II enhanced tritium overflow evoked by trains of 100 pulses at 8 Hz, an effect that was attenuated by the AT1-receptor antagonist losartan (0.3-1 microM), at concentrations suggesting the involvement of the AT1B subtype. The effect of angiotensin II was also attenuated by inhibition of phospholipase C (PLC) and protein kinase C (PKC) indicating that prejunctional AT1-receptors are coupled to the PLC-PKC pathway. Angiotensin II (0.3-100 nM) enhanced tritium overflow more markedly, up to 64%, under conditions that favor alpha2-autoinhibition, observed when stimulation consisted of 100 pulses at 8 Hz, than under poor alpha2-autoinhibition conditions, only up to 14%, observed when alpha2-adrenoceptors were blocked with yohimbine (1 microM) or when stimulation consisted of 20 pulses at 50 Hz. Activation of PKC with 12-myristate 13-acetate (PMA, 0.1-3 microM) also enhanced tritium overflow more markedly under strong alpha2-autoinhibition conditions. Inhibition of Gi/o-proteins with pertussis toxin (8 microg/ml) or blockade of Gbetagamma subunits with the anti-betagamma peptide MPS-Phos (30 microM) attenuated the effects of angiotensin II and PMA. The results indicate that activation of AT1-receptors coupled to the PLC-PKC pathway enhances noradrenaline release, an effect that is markedly favoured by an ongoing activation of alpha2-autoreceptors. Interaction between alpha2-adrenoceptors and AT1-receptors seems to involve the betagamma subunits released from the Gi/o-proteins coupled to alpha2-adrenoceptors and protein kinase C activated by AT1-receptors.
在预先用[³H]-去甲肾上腺素孵育的大鼠输精管前列腺部,研究了α₂-自身受体对血管紧张素II介导的[³H]-去甲肾上腺素释放促进作用的影响。血管紧张素II增强了8Hz 100个脉冲串诱发的氚溢出,AT₁受体拮抗剂氯沙坦(0.3 - 1μM)可减弱该效应,其浓度提示AT₁B亚型参与其中。抑制磷脂酶C(PLC)和蛋白激酶C(PKC)也可减弱血管紧张素II的作用,表明突触前AT₁受体与PLC - PKC途径偶联。当刺激为8Hz 100个脉冲时,在有利于α₂-自身抑制的条件下,血管紧张素II(0.3 - 100 nM)增强氚溢出更为明显,可达64%,而在α₂-自身抑制较差的条件下,当用育亨宾(1μM)阻断α₂-肾上腺素能受体或刺激为50Hz 20个脉冲时,仅增强14%。用12 - 肉豆蔻酸13 - 乙酸酯(PMA,0.1 - 3μM)激活PKC在强烈的α₂-自身抑制条件下也更明显地增强氚溢出。用百日咳毒素(8μg/ml)抑制Gi/o蛋白或用抗βγ肽MPS - Phos(30μM)阻断Gβγ亚基可减弱血管紧张素II和PMA的作用。结果表明,与PLC - PKC途径偶联的AT₁受体激活增强去甲肾上腺素释放,α₂-自身受体的持续激活明显有利于该效应。α₂-肾上腺素能受体与AT₁受体之间的相互作用似乎涉及从与α₂-肾上腺素能受体偶联的Gi/o蛋白释放的βγ亚基以及由AT₁受体激活的蛋白激酶C。